Prevalencia de trombocitopenia en pacientes con síndrome mielodisplásico atendidos en el Hospital Naval de Guayaquil durante el periodo 2016-2021.

Abstract

Description of the problem: Thrombocytopenia is one of the main affectations, in addition to anemia and neutropenia, which is present in patients diagnosed with myelodysplastic syndrome. It has been reported that the frequency of thrombocytopenia in myelodysplastic syndrome ranges between 40% and 65%. The main risk of thrombocytopenia in these patients is bleeding. Objective: To determine the frequency of thrombocytopenia in patients with myelodysplastic syndrome treated at the Hospital Naval during the period 2016-2021. Methods and materials: This is an observational, retrospective, cross-sectional and descriptive epidemiological study. The data was obtained from certain digital medical records in the SIS system with a total population of 51 patients. Results: In the present study it was found that the prevalence of thrombocytopenia in patients with myelodysplastic syndrome was 1.2%. Conclusion: The prevalence of thrombocytopenia in patients with myelodysplastic syndrome is low, so it remains a rare disease in our setting.